Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria

MJ Strong, S Abrahams, LH Goldstein… - … lateral sclerosis and …, 2017 - Taylor & Francis
This article presents the revised consensus criteria for the diagnosis of frontotemporal
dysfunction in amyotrophic lateral sclerosis (ALS) based on an international research …

Clinical diagnosis and management of amyotrophic lateral sclerosis

O Hardiman, LH Van Den Berg… - Nature reviews neurology, 2011 - nature.com
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that results in
progressive loss of bulbar and limb function. Patients typically die from respiratory failure …

Screening for cognition and behaviour changes in ALS

S Abrahams, J Newton, E Niven, J Foley… - … lateral sclerosis and …, 2014 - Taylor & Francis
This study presents the Edinburgh Cognitive and Behavioural ALS Screen (ECAS),
developed for ALS patients with physical disability for use by health care professionals. The …

ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS

C Crockford, J Newton, K Lonergan, T Chiwera… - Neurology, 2018 - AAN Enterprises
Objective To elucidate the relationship between disease stage in amyotrophic lateral
sclerosis (ALS), as measured with the King's Clinical Staging System, and cognitive and …

Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment

LH Goldstein, S Abrahams - The Lancet Neurology, 2013 - thelancet.com
Increased awareness of cognitive and behavioural change in amyotrophic lateral sclerosis
has been driven by various clinic-based and population-based studies. A frontotemporal …

Developing a new apathy measurement scale: Dimensional Apathy Scale

R Radakovic, S Abrahams - Psychiatry research, 2014 - Elsevier
Apathy is both a symptom and syndrome prevalent in neurodegenerative disease, including
motor system disorders, that affects motivation to display goal directed functions. Levy and …

The validation of the Italian Edinburgh cognitive and behavioural ALS screen (ECAS)

B Poletti, F Solca, L Carelli, F Madotto… - … Lateral Sclerosis and …, 2016 - Taylor & Francis
This study presents the Italian validation of the recently developed Edinburgh Cognitive and
Behavioural ALS Screen (ECAS), a short screen for cognitive/behavioural alterations in …

[HTML][HTML] Cognitive, emotional and psychological manifestations in amyotrophic lateral sclerosis at baseline and overtime: a review

S Benbrika, B Desgranges, F Eustache… - Frontiers in …, 2019 - frontiersin.org
It is now well recognized that, in addition to motor impairment, amyotrophic lateral sclerosis
(ALS) may cause extra-motor clinical signs and symptoms. These can include the alteration …

[HTML][HTML] Grey and white matter changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum

P Lillo, E Mioshi, JR Burrell, MC Kiernan, JR Hodges… - 2012 - journals.plos.org
There is increasing evidence that amyotrophic lateral sclerosis (ALS) and frontotemporal
dementia (FTD) lie on a clinical, pathological and genetic continuum with patients of one …

Multidimensional apathy in ALS: validation of the Dimensional Apathy Scale

R Radakovic, L Stephenson, S Colville… - Journal of Neurology …, 2016 - jnnp.bmj.com
Aim Apathy is a prominent symptom of amyotrophic lateral sclerosis (ALS), but measurement
is confounded by physical disability. Furthermore, it has been traditionally measured as a …